Adverse effects of FK 506 overdosage after liver transplantation.
作者信息
Alessiani M, Cillo U, Fung J J, Irish W, Abu-Elmagd K, Jain A, Takaya S, Van Thiel D, Starzl T E
机构信息
Transplant Institute of Pittsburgh, PA 15213.
出版信息
Transplant Proc. 1993 Feb;25(1 Pt 1):628-34.
Abstract
摘要
相似文献
1
Adverse effects of FK 506 overdosage after liver transplantation.肝移植后FK 506过量的不良反应。
Transplant Proc. 1993 Feb;25(1 Pt 1):628-34.
2
Association of elevated FK 506 plasma levels with nephrotoxicity in liver-grafted patients.肝移植患者中FK 506血浆水平升高与肾毒性的关联。
Transplant Proc. 1991 Dec;23(6):3153-5.
3
Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation: long-term results.肝移植后将环孢素转换为他克莫司治疗环孢素相关不良反应：长期结果
Transplant Proc. 1998 Jun;30(4):1419-21. doi: 10.1016/s0041-1345(98)00298-x.
4
Long-term insulin requirement after liver transplantation with FK 506 in American veterans.美国退伍军人肝移植后使用FK 506的长期胰岛素需求情况。
Transplant Proc. 1993 Feb;25(1 Pt 1):677-8.
5
Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
Transplant Proc. 1996 Apr;28(2):1011-3.
6
Chronic nephrotoxicity of FK 506 after liver transplantation.肝移植后FK 506的慢性肾毒性
Transplant Proc. 1994 Jun;26(3):1803.
7
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.FK506和环孢素在肝移植受者中用作初始免疫抑制时的肾毒性。
Transplant Proc. 1993 Feb;25(1 Pt 1):665-8.
8
Tacrolimus (FK 506) given three times daily after liver transplantation for minimizing nephrotoxicity and neurotoxicity.肝移植后每日三次给予他克莫司（FK 506）以将肾毒性和神经毒性降至最低。
Transplant Proc. 2003 Nov;35(7):2787-8. doi: 10.1016/j.transproceed.2003.09.009.
9
10
引用本文的文献
1
The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice.平滑肌细胞上的盐皮质激素受体促进他克莫司诱导的小鼠肾损伤。
Pharmaceutics. 2023 Apr 29;15(5):1373. doi: 10.3390/pharmaceutics15051373.
2
Effect of CYP3A4 and PPARA polymorphism on concentration-to-dose ratio and adverse effects of tacrolimus in Pakistani liver transplant recipients.CYP3A4和PPARA基因多态性对巴基斯坦肝移植受者他克莫司浓度-剂量比及不良反应的影响
Pak J Med Sci. 2022 Sep-Oct;38(7):1893-1898. doi: 10.12669/pjms.38.7.6180.
3
Novel strategy of sirolimus plus thymalfasin and huaier granule on tumor recurrence of hepatocellular carcinoma beyond the UCSF criteria following liver transplantation: A single center experience.西罗莫司联合胸腺肽α1及槐耳颗粒对肝移植后超出UCSF标准的肝细胞癌肿瘤复发的新策略：单中心经验
Oncol Lett. 2018 Oct;16(4):4407-4417. doi: 10.3892/ol.2018.9226. Epub 2018 Jul 27.
4
Late onset tacrolimus-induced life-threatening polyneuropathy in a kidney transplant recipient patient.一名肾移植受者患者出现迟发性他克莫司诱导的危及生命的多发性神经病。
Clin Kidney J. 2012 Aug;5(4):323-6. doi: 10.1093/ckj/sfs067.
5
Acute demyelinating polyneuropathy after lung transplantation: guillain-barré syndrome or tacrolimus toxicity?肺移植术后急性脱髓鞘性多发性神经病：吉兰-巴雷综合征还是他克莫司毒性？
Case Rep Transplant. 2014;2014:685010. doi: 10.1155/2014/685010. Epub 2014 Aug 11.
6
A retrospective analysis of the safety and efficacy of low dose tacrolimus (FK506) for living donor liver transplant recipients.低剂量他克莫司（FK506）用于活体供肝移植受者的安全性和有效性的回顾性分析。
J Biomed Res. 2013 Jul;27(4):305-9. doi: 10.7555/JBR.27.20130023. Epub 2013 Jun 13.
7
Tacrolimus (FK506)-Associated Renal Pathology.他克莫司（FK506）相关的肾脏病理学。
Adv Anat Pathol. 1997 Jul;4(4):265-276. doi: 10.1097/00125480-199707000-00032.
8
Daily dosing of tacrolimus in patients treated with HIV-1 therapy containing a ritonavir-boosted protease inhibitor or raltegravir.接受含利托那韦增效蛋白酶抑制剂或雷特格韦的 HIV-1 治疗的患者中他克莫司的每日剂量。
J Antimicrob Chemother. 2010 May;65(5):999-1004. doi: 10.1093/jac/dkq054. Epub 2010 Mar 4.
9
Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD.首次服用SDZ RAD后，7例肾移植患者体内SDZ RAD和环孢素及其代谢产物的药代动力学。
Br J Clin Pharmacol. 2000 Nov;50(5):449-54. doi: 10.1046/j.1365-2125.2000.00293.x.
10
Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients.他克莫司全血浓度与肾移植受者的副作用密切相关。
Br J Clin Pharmacol. 1999 Sep;48(3):445-8. doi: 10.1046/j.1365-2125.1999.00007.x.
本文引用的文献
1
EFFECT OF CYCLOSPORIN ON HEPATIC REGENERATION.环孢素对肝再生的影响。
Surg Forum. 1986;37:352-354.
2
Long-term use of cyclosporin in liver grafting.环孢素在肝移植中的长期应用。
Q J Med. 1985 Dec;57(224):897-905.
3
4
5
A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.免疫抑制剂FK506的一种受体是一种顺反肽基脯氨酰异构酶。
Nature. 1989 Oct 26;341(6244):758-60. doi: 10.1038/341758a0.
6
A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.免疫抑制剂FK506的一种胞质结合蛋白具有肽基脯氨酰异构酶活性，但与亲环蛋白不同。
Nature. 1989 Oct 26;341(6244):755-7. doi: 10.1038/341755a0.
7
A highly sensitive method to assay FK-506 levels in plasma.一种检测血浆中FK-506水平的高灵敏度方法。
Transplant Proc. 1987 Oct;19(5 Suppl 6):23-9.
8
Acute and chronic renal failure in liver transplantation.肝移植中的急性和慢性肾衰竭
Nephron. 1990;55(2):121-8. doi: 10.1159/000185938.
9
Transplantation.移植
JAMA. 1990 May 16;263(19):2686-7.
10
The spectrum of ciclosporin nephrotoxicity.
Am J Nephrol. 1990;10(4):296-309. doi: 10.1159/000168123.
Zotero 插件